Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age

Published:2019-01 Issue:1 Volume:10 Page:48-54
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Ruiz Jimmy,Miller Antonius A.,Tooze Janet A.,Crane Sandrine,Petty William J.,Gajra Ajeet^ORCID,Klepin Heidi D.

Funder

NCI Cancer Center Support Grant

Paul Beeson Career Development Award in Aging Research

NIA

AFAR

The John A. Hartford Foundation

The Atlantic Philanthropies

The Gabrielle's Angel Foundation for Cancer Research

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference57 articles.

1. Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2;Zukin;J. Clin. Oncol.,2013

2. Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy;Fiteni;Eur. Respir. J.,2016

3. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial;Quoix;Lancet,2011

4. Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice;Crawford;J. Natl. Compr. Cancer Netw.,2008

5. A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer;Dees;Cancer Investig.,2000

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database;Journal of Geriatric Oncology;2024-09

2. Frailty and Cancer Prognosis;Current Oncology Reports;2024-06-12

3. The Impact of Frailty on Chemotherapy Outcomes in Patients With Digestive System Tumors;Cancer Nursing;2024-06-12

4. A comparison of frailty measures in population-based data for patients with colorectal cancer;Age and Ageing;2024-05-01

5. Preoperative frailty screening in elderly patients with non-small cell lung cancer surgery: an essential step for a good surgical outcome;Expert Review of Respiratory Medicine;2024-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3